AMIT Technion
Digital Health Speech Technologies
Artificial Intelligence Natural Language Processing Speech Recognition

Investor Overview

University
Investor Type
Alfred E. Mann established the Alfred Mann Institute for Biomedical Development at Technion-Israel Institute of Technology AMIT is, focused on enabling commercialization of innovative biomedical technologies that improve human health.

Investment Preference

Series
Seed, Series A
Business Model
B2B, B2B2C, B2C, B2G
Offering Type
Software
AI Type
Artificial Intelligence Natural Language Processing Speech Recognition
Sectors
Digital Health Speech Technologies

Investment Portfolio

Startup

Operating Status

Offering Type

Business Model

Total Funding

AI Employees

Voiceitt
Active
Software
B2B, B2B2C, B2C, B2G
$15.8 M
6

Investment Rounds History

2

Funding Rounds

Startup

Date Announced

Funding Round

Amount Raised

Investors

More Investors

AMIT Technion
University
Agrinnovation Fund
Investment Firm

Investor Snapshot

Average Funding Round Size

$6 Million

No. of Investments

2

No. of Portfolio Companies

1

Largest Funding Round Size

$10 Million

Sign up for free

  • Save profiles to your list
  • View all funding rounds
  • Advanced sorting filter access
  • Search investment rounds
  • Search exit events

Sign up for Pro

You reached your page view limit

  • Bulk export lists (CSV, Excel)
  • View verified email contacts
  • Browse all profile types
  • Unlimited views
  • Advanced filters, sorting and search
  • Starting at just $15 per month

Sign up for free

You reached your page view limit

  • Save profiles to your list
  • View all funding rounds
  • Advanced sorting filter access
  • Search investment rounds
  • Search exit events